Lemborexant
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders
Trial Timeline
Oct 17, 2020 → Mar 17, 2022
NCT ID
NCT04573556About Lemborexant
Lemborexant is a pre-clinical stage product being developed by Eisai for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT04573556. Target conditions include Sleep Initiation and Maintenance Disorders.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05594589 | Phase 2 | Completed |
| NCT04890561 | Phase 1 | Completed |
| NCT04555733 | Phase 1 | Completed |
| NCT04573556 | Pre-clinical | Completed |
| NCT03443063 | Phase 1 | Completed |
| NCT03440424 | Phase 1 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders